PB2008 AN OPEN-LABEL STUDY OF BENDAMUSTINE HYDROCHLORIDE IN CHINESE PATIENTS WITH INDOLENT NON-HODGKIN LYMPHOMA (NHL) REFRACTORY TO RITUXIMAB TREATMENT

10.1097/01.hs9.0000566524.82977.2b ◽

2019 ◽

Vol 3 (S1) ◽

pp. 908

Author(s):

Y. Shi ◽

X. Hong ◽

H. Huang ◽

W. Xu ◽

X. Han ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Chinese Patients ◽

Open Label Study ◽

Label Study ◽

Non Hodgkin Lymphoma

Download Full-text

A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-12-3349 ◽

2013 ◽

Vol 19 (13) ◽

pp. 3659-3670 ◽

Author(s):

Razelle Kurzrock ◽

Peter M. Voorhees ◽

Corey Casper ◽

Richard R. Furman ◽

Luis Fayad ◽

...

Keyword(s):

Multiple Myeloma ◽

Monoclonal Antibody ◽

Phase I ◽

B Cell ◽

Hodgkin Lymphoma ◽

Castleman Disease ◽

Open Label Study ◽

Label Study ◽

Non Hodgkin Lymphoma

Download Full-text

Abstract PO-63: A phase 2a open-label study of MT-3724, a novel CD20-targeting engineered toxin body, in combination with lenalidomide (LEN) in subjects with relapsed or refractory B-cell non-Hodgkin lymphoma (NHL)

10.1158/2643-3249.lymphoma20-po-63 ◽

2020 ◽

Author(s):

Jason Tache ◽

Deborah A. Katz ◽

Amitabha Mazumder ◽

David Peace ◽

Christine Burnett ◽

...

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Open Label Study ◽

Label Study ◽

Non Hodgkin Lymphoma

Download Full-text

A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid®) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: The EXPECT trial

European Journal of Cancer ◽

10.1016/j.ejca.2013.04.029 ◽

2013 ◽

Vol 49 (13) ◽

pp. 2869-2876 ◽

Author(s):

Franck Morschhauser ◽

Olivier Fitoussi ◽

Corinne Haioun ◽

Catherine Thieblemont ◽

Hang Quach ◽

...

Keyword(s):

T Cell ◽

Hodgkin Lymphoma ◽

Single Agent ◽

Phase 2 ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Non Hodgkin Lymphoma

Download Full-text

Preliminary findings from a phase I, multicenter, open-label study of the anti-CD37 antibody-drug conjugate (ADC), IMGN529, in adult patients with relapsed or refractory non-Hodgkin lymphoma (NHL).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.8526 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 8526-8526 ◽

Author(s):

Anastasios Stathis ◽

Kami J. Maddocks ◽

Ian Flinn ◽

Alex Mejia ◽

Maria Lia Palomba ◽

...

Keyword(s):

Phase I ◽

Hodgkin Lymphoma ◽

Adult Patients ◽

Antibody Drug Conjugate ◽

Open Label Study ◽

Label Study ◽

Drug Conjugate ◽

Non Hodgkin Lymphoma ◽

Download Full-text

Mometasone furoate nasal spray reduces symptoms and improves quality of life in Chinese patients with moderate to severe allergic rhinitis: a multicenter open-label study

Acta Oto-Laryngologica ◽

10.1080/00016480902856570 ◽

2009 ◽

pp. 1-6

Author(s):

Luo Zhang ◽

Geng Xu ◽

Xiangdong Wang ◽

Shixi Liu ◽

Yuan Li ◽

...

Keyword(s):

Quality Of Life ◽

Allergic Rhinitis ◽

Nasal Spray ◽

Mometasone Furoate ◽

Chinese Patients ◽

Open Label Study ◽

Download Full-text

Efficacy and safety of lanreotide autogel compared with lanreotide 40 mg prolonged release in Chinese patients with active acromegaly: results from a phase 3, prospective, randomized, and open-label study (LANTERN)

BMC Endocrine Disorders ◽

10.1186/s12902-020-0524-7 ◽

2020 ◽

Vol 20 (1) ◽

Author(s):

Zhenmei An ◽

◽

Ting Lei ◽

Lian Duan ◽

Pei Hu ◽

...

Keyword(s):

Chinese Patients ◽

Prolonged Release ◽

Efficacy And Safety ◽

Phase 3 ◽

Open Label Study ◽

Label Study ◽

Active Acromegaly ◽

Lanreotide Autogel

Download Full-text

43 A multicenter, randomized, open-label study of peginterferon alpha-2b vs interferon alpha-2b for the treatment of chinese patients with HBeAg+VE chronic hepatitis B

Journal of Hepatology ◽

10.1016/s0168-8278(06)80044-9 ◽

2006 ◽

Vol 44 ◽

pp. S20-S21 ◽

Author(s):

H. Zhao ◽

C.-W. Si ◽

L. Wei ◽

M.-B. Wan ◽

Y.-K. Ying ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Interferon Alpha ◽

Chinese Patients ◽

Open Label Study ◽

Label Study ◽

Interferon Alpha 2B

Download Full-text

Pharmacokinetics, Pharmacodynamics and Safety of Belimumab in Chinese Patients with Systemic Lupus Erythematosus: A Phase I, Open-Label Study

Rheumatology and Therapy ◽

10.1007/s40744-020-00193-9 ◽

2020 ◽

Vol 7 (1) ◽

pp. 191-200

Author(s):

Jing Zhang ◽

Weiguo Wan ◽

Liyan Miao ◽

Jian Wu ◽

Jun Dong ◽

...

Keyword(s):

Systemic Lupus Erythematosus ◽

Phase I ◽

Lupus Erythematosus ◽

Chinese Patients ◽

Systemic Lupus ◽

Open Label Study ◽

Download Full-text

Pharmacokinetics, Safety, and Preliminary Efficacy of Oral Trifluridine/Tipiracil in Chinese Patients with Solid Tumors: A Phase 1b, Open-Label Study

Clinical Pharmacology Advances and Applications ◽

10.2147/cpaa.s232104 ◽

2020 ◽

Vol Volume 12 ◽

pp. 21-33

Author(s):

Xicheng Wang ◽

Jianfeng Zhou ◽

Yan Li ◽

Yuping Ge ◽

Yanping Zhou ◽

...

Keyword(s):

Solid Tumors ◽

Chinese Patients ◽

Open Label Study ◽

Label Study ◽

Download Full-text

Faculty of 1000 evaluation for Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody Lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718174994.793487135 ◽

2013 ◽

Author(s):

Nicolas Mounier

Keyword(s):

Monoclonal Antibody ◽

Hodgkin Lymphoma ◽

Adult Patients ◽

Open Label Study ◽

Download Full-text